Dual effect of serum amyloid A on the invasiveness of glioma cells.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3596950)

Published in Mediators Inflamm on February 25, 2013

Authors

Franciele Hinterholz Knebel1, Renata Chaves Albuquerque, Renato Ramos Massaro, Silvya Stuchi Maria-Engler, Ana Campa

Author Affiliations

1: Departamento de Análises Clínicas e Toxicológicas, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Avenida Prof. Lineu Prestes, 580 Cidade Universitária, 05508-000 São Paulo, SP, Brazil.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Cancer-related inflammation. Nature (2008) 34.21

New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer (2002) 24.71

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev (2007) 21.13

Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res (1991) 6.99

Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem (1999) 4.94

Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer (2003) 4.78

Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol (1999) 4.15

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58

Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol (1997) 3.02

Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci (2009) 2.75

Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst (2007) 2.57

Concomitant S-, N-, and heme-nitros(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo. FASEB J (2002) 2.46

A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med (1999) 2.32

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med (1994) 2.18

Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol (2000) 2.11

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin Cancer Res (2004) 2.07

Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int (2002) 2.04

Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol (2001) 1.85

Signal transduction of inflammatory cytokines and tumor development. Cancer Sci (2006) 1.78

A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun (2000) 1.65

Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. Eur Urol (2009) 1.57

Serum amyloid A: an acute-phase protein involved in tumour pathogenesis. Cell Mol Life Sci (2009) 1.57

Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol (2008) 1.50

Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci (2008) 1.49

Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells. Biochem Biophys Res Commun (2005) 1.40

Human serum amyloid A has cytokine-like properties. Scand J Immunol (1998) 1.39

Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest (1998) 1.20

Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma. Cancer (2004) 1.16

Genetic variants in inflammation pathway genes and asthma in glioma susceptibility. Neuro Oncol (2010) 1.15

Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum (2006) 1.15

mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm (2003) 1.11

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1. Proteomics (2005) 1.10

Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol (2010) 1.10

New molecular targets in angiogenic vessels of glioblastoma tumours. Expert Rev Mol Med (2008) 1.08

Extrahepatic production of acute phase serum amyloid A. Histol Histopathol (2005) 1.07

Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur J Immunol (2005) 1.06

Inducible NO synthase confers chemoresistance in head and neck cancer by modulating survivin. Int J Cancer (2009) 1.01

Cytokine production of lung cancer cell lines: Correlation between their production and the inflammatory/immunological responses both in vivo and in vitro. Cancer Sci (2007) 1.01

Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol Lett (2004) 1.01

Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro. Anticancer Res (2008) 0.98

The acute phase protein serum amyloid A primes neutrophils. FEMS Immunol Med Microbiol (2003) 0.96

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma. J Neurooncol (2010) 0.95

Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. J Cancer Res Clin Oncol (2002) 0.94

Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J Immunol (1996) 0.93

The role of circulating IL-8 and VEGF protein in the progression of gastric cancer. Cancer Sci (2003) 0.92

Serum amyloid A enhances plasminogen activation: implication for a role in colon cancer. Biochem Biophys Res Commun (2008) 0.90

Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast. Clin Exp Immunol (2010) 0.89

Serum amyloid A is a growth factor for 3T3-L1 adipocytes, inhibits differentiation and promotes insulin resistance. Int J Obes (Lond) (2011) 0.88

Molecular biology of glioma tumorigenesis. Histol Histopathol (2003) 0.88

Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. Brain Res (2008) 0.85

Molecular interactions of acute phase serum amyloid A: possible involvement in carcinogenesis. Biochemistry (Mosc) (2006) 0.84

Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signaling pathways. Immunol Lett (2008) 0.83

Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer. Oncogene (1998) 0.81

ADAM23 methylation and expression analysis in brain tumors. Neurosci Lett (2005) 0.79

Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells. J Neurooncol (2006) 0.76

Articles by these authors

Is serum amyloid A an endogenous TLR4 agonist? J Leukoc Biol (2008) 1.50

mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm (2003) 1.11

Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detect Prev (2002) 1.08

Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A. Immunol Lett (2004) 1.07

Genetic analysis of the response to eleven Colletotrichum lindemuthianum races in a RIL population of common bean (Phaseolus vulgaris L.). BMC Plant Biol (2014) 1.01

Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol Lett (2004) 1.01

Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis. J Rheumatol (2007) 1.00

Interaction between serum amyloid A and leukocytes - a possible role in the progression of vascular complications in diabetes. Immunol Lett (2007) 1.00

Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol (2006) 0.99

The acute phase protein serum amyloid A primes neutrophils. FEMS Immunol Med Microbiol (2003) 0.96

Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness. J Cell Biochem (2006) 0.92

Sodium chloride inhibits cytokine production by lipopolysaccharide-stimulated human neutrophils and mononuclear cells. Shock (2007) 0.92

Introgression and pyramiding into common bean market class fabada of genes conferring resistance to anthracnose and potyvirus. Theor Appl Genet (2011) 0.89

Macrophage activation includes high intracellular myeloperoxidase activity. Biochem Biophys Res Commun (2002) 0.88

High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism. J Pineal Res (2005) 0.87

Molecular mapping and intra-cluster recombination between anthracnose race-specific resistance genes in the common bean differential cultivars Mexico 222 and Widusa. Theor Appl Genet (2008) 0.87

RECK-mediated inhibition of glioma migration and invasion. J Cell Biochem (2010) 0.87

Mapping of QTLs for morpho-agronomic and seed quality traits in a RIL population of common bean (Phaseolus vulgaris L.). Theor Appl Genet (2010) 0.87

HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis. PLoS One (2012) 0.86

The acute-phase proteins serum amyloid A and C reactive protein in transudates and exudates. Mediators Inflamm (2006) 0.85

Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin. Tissue Eng Part A (2014) 0.85

Superoxide-dependent oxidation of melatonin by myeloperoxidase. J Biol Chem (2005) 0.84

The term basal plate of the human placenta as a source of functional extravillous trophoblast cells. Reprod Biol Endocrinol (2014) 0.84

Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes. J Pineal Res (2004) 0.84

Serum amyloid A induces CCL20 secretion in mononuclear cells through MAPK (p38 and ERK1/2) signaling pathways. Immunol Lett (2008) 0.83

Apolipoproteins A-I and A-II downregulate neutrophil functions. Lipids (2002) 0.83

Apoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy. PLoS One (2013) 0.82

Analysis of chemokines and reactive oxygen species formation by rat and human neutrophils induced by microcystin-LA, -YR and -LR. Toxicon (2008) 0.82

Maternal and cord blood levels of serum amyloid A, C-reactive protein, tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 during and after delivery. Mediators Inflamm (2005) 0.81

Melatonin protects CD4+ T cells from activation-induced cell death by blocking NFAT-mediated CD95 ligand upregulation. J Immunol (2010) 0.81

Hybrid scaffolds built from PET and collagen as a model for vascular graft architecture. Macromol Biosci (2012) 0.81

Melatonin and its kynurenin-like oxidation products affect the microbicidal activity of neutrophils. Microbes Infect (2005) 0.80

Late effects of sleep restriction: Potentiating weight gain and insulin resistance arising from a high-fat diet in mice. Obesity (Silver Spring) (2014) 0.80

Intracellular localization of myeloperoxidase in murine peritoneal B-lymphocytes and macrophages. Cell Immunol (2013) 0.79

The curcumin analog DM-1 induces apoptotic cell death in melanoma. Tumour Biol (2013) 0.79

Hypoxia increases serum amyloid A3 (SAA3) in differentiated 3T3-L1 adipocytes. Inflammation (2013) 0.79

Effects of microcystins on human polymorphonuclear leukocytes. Biochem Biophys Res Commun (2006) 0.78

Cell cycle arrest, extracellular matrix changes and intrinsic apoptosis in human melanoma cells are induced by Boron Neutron Capture Therapy. Toxicol In Vitro (2013) 0.78

Genetic mapping of two genes conferring resistance to powdery mildew in common bean (Phaseolus vulgaris L.). Theor Appl Genet (2013) 0.77

Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy. Radiat Environ Biophys (2012) 0.77

Interferon-gamma independent oxidation of melatonin by macrophages. J Pineal Res (2003) 0.77

Tryptamine and dimethyltryptamine inhibit indoleamine 2,3 dioxygenase and increase the tumor-reactive effect of peripheral blood mononuclear cells. Cell Biochem Funct (2013) 0.77

High-density lipoprotein prevents SAA-induced production of TNF-α in THP-1 monocytic cells and peripheral blood mononuclear cells. Mem Inst Oswaldo Cruz (2011) 0.76

Indoleamine 2,3-dioxygenase (IDO) activity in placental compartments of renal-transplanted pregnant women. Am J Reprod Immunol (2014) 0.76

The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells. FEBS J (2013) 0.75

Melanocytes are more responsive to IFN-γ and produce higher amounts of kynurenine than melanoma cells. Biol Chem (2016) 0.75

Assessment of monocytic component in acute myelomonocytic and monocytic/monoblastic leukemias by a chemiluminescent assay. Hematol J (2003) 0.75

Cytotoxicity of PVPAC-treated bovine pericardium: a potential replacement for glutaraldehyde in biological heart valves. J Biomed Mater Res B Appl Biomater (2013) 0.75

Introgressed Genomic Regions in a Set of Near-Isogenic Lines of Common Bean Revealed by Genotyping-by-Sequencing. Plant Genome (2017) 0.75